![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Canada’s Medicago Begins Phase 1 Trial of Plant-Based COVID-19 Vaccine
Canada’s Medicago Begins Phase 1 Trial of Plant-Based COVID-19 Vaccine
![Canada flag](https://www.fdanews.com/ext/resources/test/Drug-Images4/Canada_Flag.gif?t=1627934481&width=430)
Canadian drugmaker Medicago has begun a phase 1 clinical trial of its plant-based COVID-19 vaccine in healthy volunteers.
The trial will evaluate the vaccine in 180 healthy male and female subjects ages 18-55 at three different dosage levels of the vaccine, either alone or with adjuvants from GlaxoSmithKline and Dynavax.
Medicago plans to begin a phase 2/3 trial of the vaccine in October.
Upcoming Events
-
21Oct